Preimplantation Genetic Screening PGS Test sale cost 3280 AED
Genetic Mapping for Gynecological Disorders Test sale cost 3980 AED Genetic Mapping for Gynecological Disorders Test Cost 4,420 د.إ Original price was: 4,420 د.إ.3,980 د.إCurrent price is: 3,980 د.إ.
FISH - Prenatal Comprehensive Screening Panel 1 Test sale cost 2570 AED FISH - Prenatal Comprehensive Screening Panel 1 Test Cost 2,860 د.إ Original price was: 2,860 د.إ.2,570 د.إCurrent price is: 2,570 د.إ.
Sale!

Preimplantation Genetic Screening PGS Test Cost

Original price was: 3,640 د.إ.Current price is: 3,280 د.إ.

-10%

Preimplantation Genetic Screening (PGS), also known as Preimplantation Genetic Testing for Aneuploidies (PGT-A), is a cutting-edge procedure that is performed on embryos produced through in vitro fertilization (IVF) before their transfer to the uterus. This test is designed to examine the embryos for any chromosomal abnormalities that could lead to genetic disorders, miscarriage, or failure to implant. By ensuring that only genetically healthy embryos are implanted, PGS aims to increase the chances of a successful pregnancy and the birth of a healthy child.

At DNA Labs UAE, the PGS test is available for a cost of 3280 AED. The facility employs state-of-the-art genetic testing technologies to analyze the chromosomes of embryos with high precision. This screening process involves taking a few cells from each embryo, typically at the blastocyst stage, to evaluate all 23 pairs of chromosomes for any abnormalities. The result of this comprehensive screening aids in selecting the best embryo(s) for transfer, significantly improving the outcomes of IVF treatments. DNA Labs UAE provides expert counseling and support throughout the process, ensuring that couples understand the benefits, limitations, and implications of PGS testing.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PREIMPLANTATION GENETIC SCREENING (PGS) Test

Test Name: PREIMPLANTATION GENETIC SCREENING (PGS) Test

Components: Price – 3280.0 AED

Sample Condition: Submit biopsied embryo cells in a special tube available from LPL. In case of multiple embryos being tested, submit a separate tube for each embryo with a separate Lab No. @ 14,000 AED per embryo. Ship frozen in special transport containers available from LPL. Duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory. Sample to be collected & dispatched with prior appointment.

Report Delivery: Sample to be collected on Tuesday by 9 am; Report delivered the following Tuesday

Method: Next Generation Sequencing

Test Type: Infertility, Genetic testing

Doctor: Gynecologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Sample to be collected & dispatched with prior appointment. Duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory.

Test Details

Preimplantation Genetic Screening (PGS) is a test performed during in vitro fertilization (IVF) to screen embryos for chromosomal abnormalities before they are implanted into the uterus. It involves the biopsy of a few cells from the embryo, which are then analyzed for any genetic abnormalities.

The main purpose of PGS is to select embryos that have a normal number of chromosomes (euploid embryos) and exclude those with an abnormal number of chromosomes (aneuploid embryos). This is particularly useful for couples who have a high risk of passing on genetic disorders or for women of advanced maternal age, as chromosomal abnormalities increase with age.

The PGS test can detect various chromosomal abnormalities, such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and sex chromosome abnormalities. It can also identify structural chromosomal abnormalities, such as translocations.

The PGS process involves the following steps:

  1. IVF: The woman undergoes ovarian stimulation to produce multiple eggs, which are then retrieved and fertilized with sperm in a laboratory to create embryos.
  2. Embryo biopsy: Typically on day 5 or 6 of development, a few cells are removed from each embryo using a specialized technique, such as trophectoderm biopsy.
  3. Genetic analysis: The biopsied cells are sent to a laboratory, where they undergo genetic analysis. This can be done using various techniques, including array comparative genomic hybridization (aCGH) or next-generation sequencing (NGS).
  4. Embryo selection: The genetic analysis results are used to determine which embryos are euploid and free of chromosomal abnormalities. These selected embryos are then chosen for transfer into the uterus.
  5. Embryo transfer: The selected embryos are transferred into the woman’s uterus, with the aim of achieving a successful pregnancy.

PGS has several potential benefits, including increased pregnancy rates, reduced risk of miscarriage, and the ability to select embryos free of certain genetic disorders. However, it also has limitations, such as the potential for false-positive or false-negative results, the possibility of embryo damage during biopsy, and the ethical concerns associated with embryo selection.

It is important to consult with a fertility specialist or genetic counselor to determine if PGS is appropriate for your specific situation and to discuss the potential risks and benefits involved.

Test Name PREIMPLANTATION GENETIC SCREENING PGS Test
Components
Price 3280.0 AED
Sample Condition Submit biopsiedEmbryo cellsin special tube available from LPL. In case of multiple embryos being tested, submit separate tube for each embryo with separate Lab No. @ 14,000\ per embryo. Ship frozen in special transport containers available from LPL. Duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory. Sample to be collected & dispatched with prior appointment.
Report Delivery Sample Tue by 9 am; Report Next Tue
Method Next Generation Sequencing
Test type Infertility, Genetic testing
Doctor Gynecologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Sample to be collected & dispatched with prior appointment. Duly filled Preimplantation Genetic Screening Consent form (Form 23) is mandatory.
Test Details

Preimplantation Genetic Screening (PGS) is a test performed during in vitro fertilization (IVF) to screen embryos for chromosomal abnormalities before they are implanted into the uterus. It involves the biopsy of a few cells from the embryo, which are then analyzed for any genetic abnormalities.

The main purpose of PGS is to select embryos that have a normal number of chromosomes (euploid embryos) and exclude those with an abnormal number of chromosomes (aneuploid embryos). This is particularly useful for couples who have a high risk of passing on genetic disorders or for women of advanced maternal age, as chromosomal abnormalities increase with age.

The PGS test can detect various chromosomal abnormalities, such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and sex chromosome abnormalities. It can also identify structural chromosomal abnormalities, such as translocations.

The PGS process involves the following steps:

1. IVF: The woman undergoes ovarian stimulation to produce multiple eggs, which are then retrieved and fertilized with sperm in a laboratory to create embryos.

2. Embryo biopsy: Typically on day 5 or 6 of development, a few cells are removed from each embryo using a specialized technique, such as trophectoderm biopsy.

3. Genetic analysis: The biopsied cells are sent to a laboratory, where they undergo genetic analysis. This can be done using various techniques, including array comparative genomic hybridization (aCGH) or next-generation sequencing (NGS).

4. Embryo selection: The genetic analysis results are used to determine which embryos are euploid and free of chromosomal abnormalities. These selected embryos are then chosen for transfer into the uterus.

5. Embryo transfer: The selected embryos are transferred into the woman’s uterus, with the aim of achieving a successful pregnancy.

PGS has several potential benefits, including increased pregnancy rates, reduced risk of miscarriage, and the ability to select embryos free of certain genetic disorders. However, it also has limitations, such as the potential for false-positive or false-negative results, the possibility of embryo damage during biopsy, and the ethical concerns associated with embryo selection.

It is important to consult with a fertility specialist or genetic counselor to determine if PGS is appropriate for your specific situation and to discuss the potential risks and benefits involved.

SKU: TEST-4748 Category:

Related products